ERRO, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 5.305
EU - Europa 1.675
AS - Asia 889
AF - Africa 3
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.880
Nazione #
US - Stati Uniti d'America 5.288
IT - Italia 560
CN - Cina 414
UA - Ucraina 348
IE - Irlanda 287
TR - Turchia 267
SE - Svezia 167
VN - Vietnam 163
DE - Germania 147
RU - Federazione Russa 57
FI - Finlandia 47
IN - India 36
GB - Regno Unito 29
CA - Canada 10
CZ - Repubblica Ceca 9
JP - Giappone 6
MX - Messico 6
BE - Belgio 4
AU - Australia 3
FR - Francia 3
LT - Lituania 3
PL - Polonia 3
CL - Cile 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
MD - Moldavia 2
NO - Norvegia 2
ZA - Sudafrica 2
BR - Brasile 1
DK - Danimarca 1
ES - Italia 1
HR - Croazia 1
IR - Iran 1
MA - Marocco 1
ME - Montenegro 1
NL - Olanda 1
PA - Panama 1
Totale 7.880
Città #
Ann Arbor 1.219
Princeton 848
Chandler 538
Wilmington 493
Jacksonville 427
Dublin 287
Izmir 265
Woodbridge 216
Ashburn 190
Houston 188
Salerno 181
Dong Ket 162
Andover 127
Pellezzano 121
Nanjing 115
Naples 82
Beijing 75
Boardman 69
Norwalk 69
Fairfield 62
Düsseldorf 44
Shenyang 43
Hebei 36
Nanchang 34
Pune 34
Dearborn 29
Changsha 28
Mestre 27
West Jordan 27
Jiaxing 26
San Diego 23
Redwood City 22
Cambridge 15
Seattle 15
Washington 15
Los Angeles 13
Tianjin 13
Falls Church 12
Lecce 11
Orange 10
Brno 9
Rome 8
Jinan 7
London 7
Toronto 7
Assago 6
Dormagen 6
Milan 6
Lappeenranta 5
New York 5
Perugia 5
Santa Maria A Vico 5
Brussels 4
Fort Worth 4
Kunming 4
Marigliano 4
Munich 4
Canzo 3
Casoria 3
Fuzhou 3
Guangzhou 3
Hefei 3
Menlo Park 3
Mercato San Severino 3
Mountain View 3
Porto Recanati 3
Vilnius 3
Walnut 3
Aiello Del Sabato 2
Atella 2
Camarillo 2
Chełmża 2
Dallas 2
Delhi 2
Eboli 2
Edinburgh 2
Fremont 2
Freyburg 2
Fucecchio 2
Gaeta 2
Gunzenhausen 2
Islington 2
Johannesburg 2
Lanzhou 2
Nagoya 2
Nokia 2
Nürnberg 2
Oslo 2
Ottawa 2
Santiago 2
Sorrento 2
Taizhou 2
Thessaloniki 2
Wenzhou 2
Zhengzhou 2
Airdrie 1
Albany 1
Amsterdam 1
Bologna 1
Caserta 1
Totale 6.399
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 120
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 116
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 107
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 103
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 103
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 101
Increased bilirubin levels in de novo Parkinson's disease 98
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 97
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 95
Malabsorption is uncommon in restless legs syndrome. 89
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 86
On the relationship between side of onset and cognition in Parkinson disease 83
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 82
Gender and non motor fluctuations in Parkinson's disease: A prospective study 81
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 80
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 79
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 79
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 78
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 78
Quitting smoking: An early non-motor feature of Parkinson's disease? 77
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 77
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 76
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 74
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 72
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 72
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 71
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 71
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 68
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 68
Uric acid relates to dopamine transporter availability in Parkinson's disease. 67
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 67
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 67
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 67
Abnormal eating behaviors in progressive supranuclear palsy. 66
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 65
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 64
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 64
Early MRI findings in acquired hepatocerebral degeneration. 63
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 63
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 62
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 62
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 61
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 60
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 59
Non-motor correlates of smoking habits in de novo Parkinson's disease 59
The "eye of the tiger" sign in pure akinesia with gait freezing. 57
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 56
Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study. 55
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 55
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 55
Hemi-restless legs syndrome induced by clebopride 54
Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 cases 53
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 53
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 53
Progressive Parkinsonism, Balance Difficulties, and Supranuclear Gaze Palsy 52
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 51
Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation 49
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials 48
Mild cognitive impairment in drug-naive patients with PD is associated withcerebral hypometabolism 47
Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 47
Restless legs syndrome is a common feature of adult celiac disease 47
Neurophysiological correlates of abnormal somatosensory temporal discrimination in dystonia 46
Nutritional habits, risk, and progression of Parkinson disease 45
“Atypical” atypical parkinsonism: Critical appraisal of a cohort 45
ADCY5 mutations are another cause of benign hereditary chorea 45
The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review 44
When shaking during standing points to hereditary spastic paraplegias 41
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 41
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 41
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 41
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 39
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 37
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies 36
Why do people google movement disorders? An infodemiological study of information seeking behaviors 36
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray 36
Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials 36
Midbrain MRI assessments in progressive supranuclear palsy subtypes 36
Does rest tremor exclude the diagnosis of adult-onset primary dystonia? 35
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 35
The Distinguishing Motor Features of Cataplexy: A Study from Video Recorded Attacks 34
Facial emotion recognition and expression in Parkinson's disease: An emotional mirror mechanism? 34
Diagnostic challenges of Parkinsonism occurring in multiple sclerosis 34
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 34
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 33
Mental rotation and working memory in musicians’ dystonia 33
SPG31 presenting with orthostatic tremor. 33
Case Studies in Movement Disorders - Common and Uncommon Presentations 33
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 32
Non-invasive brain stimulation for dystonia: therapeutic implications 32
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 32
Early Ataxia and Subsequent Parkinsonism: PLA2G6 Mutations Cause a Continuum Rather Than Three Discrete Phenotypes 31
Classic PD-like rest tremor associated with the tau p.R406W mutation 31
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 31
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 31
Parkinsonism following neuroleptic exposure: a double-hit hypothesis? 30
Cortical pencil lining in neuroferritinopathy: A diagnostic clue 30
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. 29
On the long-term outcome of orthostatic tremor 29
Propriospinal myoclonus: Clinical reappraisal and review of literature 29
Functional gait disorders: Demographic and clinical correlations 29
Totale 5.708
Categoria #
all - tutte 32.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.952


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019327 0 0 0 0 0 0 0 0 0 0 305 22
2019/20201.001 336 49 118 6 32 13 59 17 52 53 243 23
2020/2021679 2 45 57 11 77 60 70 6 58 2 81 210
2021/20221.275 5 1 5 9 24 8 17 37 146 164 216 643
2022/20231.556 242 102 73 141 171 371 18 129 202 8 66 33
2023/2024696 45 132 57 61 46 120 37 77 49 66 6 0
Totale 8.424